These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32500725)

  • 1. Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
    Naccarelli GV; Bhatt DL; Camm AJ; Le Heuzey JY; Lombardi F; Tamargo J; Martinez JM; Naditch-Brûlé L;
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):425-437. PubMed ID: 32500725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dronedarone started rapidly after amiodarone discontinuation.
    Immordino L; Connolly S; Crijns H; Roy D; Capucci A; Radzik D; Aliot E; Hohnloser S; Kowey P
    Clin Cardiol; 2013 Feb; 36(2):88-95. PubMed ID: 23338943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of dronedarone in patients with amiodarone-induced hyperthyroidism: a clinical study.
    Perrone MA; Babu Dasari J; Intorcia A; Morgagni R; Sergi D; Battaini F; De Lorenzo A; Bernardini S; Merra G; Romeo F
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8502-8508. PubMed ID: 30556893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dronedarone.
    Tamargo J; López-Farré A; Caballero R; Delpón E
    Drugs Today (Barc); 2011 Feb; 47(2):109-33. PubMed ID: 21431100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study.
    Le Heuzey JY; De Ferrari GM; Radzik D; Santini M; Zhu J; Davy JM
    J Cardiovasc Electrophysiol; 2010 Jun; 21(6):597-605. PubMed ID: 20384650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
    Ezekowitz MD; Ellenbogen KA; DiMarco JP; Kaszala K; Boddy A; Geba GP; Koren A
    J Interv Card Electrophysiol; 2015 Mar; 42(2):69-76. PubMed ID: 25638303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dronedarone: an emerging agent with rhythm- and rate-controlling effects.
    Wegener FT; Ehrlich JR; Hohnloser SH
    J Cardiovasc Electrophysiol; 2006 Sep; 17 Suppl 2():S17-20. PubMed ID: 16939434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dronedarone: a review of characteristics and clinical data.
    Baroletti S; Catella J; Ehle M; Cheng JW
    Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dronedarone: a promising alternative for the management of atrial fibrillation.
    Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Garcia D; Cheng-Lai A
    Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
    Guerra F; Hohnloser SH; Kowey PR; Crijns HJ; Aliot EM; Radzik D; Roy D; Connolly S; Capucci A
    Clin Cardiol; 2014 Dec; 37(12):717-24. PubMed ID: 25470298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
    Thind M; Crijns HJ; Naccarelli GV; Reiffel JA; Corp Dit Genti V; Wieloch M; Koren A; Kowey PR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1022-1030. PubMed ID: 32083368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
    Burashnikov A; Belardinelli L; Antzelevitch C
    Heart Rhythm; 2010 Sep; 7(9):1273-9. PubMed ID: 20478403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety profile of dronedarone in clinical practice. Results of the Magdeburg Dronedarone Registry (MADRE study).
    Said SM; Esperer HD; Kluba K; Genz C; Wiedemann AK; Boenigk H; Herold J; Schmeisser A; Braun-Dullaeus RC
    Int J Cardiol; 2013 Sep; 167(6):2600-4. PubMed ID: 22781508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dronedarone for the treatment of atrial fibrillation and atrial flutter.
    Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic profile of dronedarone , a new antiarrhythmic agent for the treatment of atrial fibrillation.
    Rosa GM; Bianco D; Parodi A; Valbusa A; Zawaideh C; Bizzarri N; Ferrero S; Brunelli C
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1751-64. PubMed ID: 25349898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
    Page RL; Connolly SJ; Crijns HJ; van Eickels M; Gaudin C; Torp-Pedersen C; Hohnloser SH;
    Am J Cardiol; 2011 Apr; 107(7):1019-22. PubMed ID: 21296333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone after surgical ablation for atrial fibrillation: Is it really necessary? A prospective randomized controlled trial.
    Ad N; Holmes SD; Shuman DJ; Pritchard G; Miller CE
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):798-803. PubMed ID: 26253874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Prolonged Use of Dronedarone on Recurrence in Patients with Non-Paroxysmal Atrial Fibrillation After Radiofrequency Ablation (DORIS): Rationale and Design of a Randomized Multicenter, Double-Blinded Placebo-Controlled Trial.
    Wu Y; Fan F; Yu J; Zhou J; Xie X; Xia G; Zhong D; Cheng D; Zhang B; Wang X; Chen Z; Wang S; Li X; Yang B
    Cardiovasc Drugs Ther; 2024 Oct; 38(5):1047-1052. PubMed ID: 37155004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
    Duray GZ; Schmitt J; Hohnloser SH
    J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):19S-23S. PubMed ID: 20472812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.